Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Interim Data from Phase 2 Study Showed 93% of People with Hepatitis C Who Received a Total of 12 Weeks of a Combination Regimen Including INCIVEK™ (telaprevir) and VX-222 (400mg) Achieved a Viral Cure (SVR)
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:48pm
tags:
VX-222, Incivek, Vertex Pharmaceuticals
Positive Interim Data From a Phase 2 Study of INCIVEK™ (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting®
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:47pm
tags:
Incivek, Vertex Pharmaceuticals, hepatitis C, HIV
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:46pm
tags:
Viread, Gilead Sciences, hepatitis B
Sequenom CEO Discusses Q3 2011 Results - Earnings Call Transcript
Seeking Alpha
Saturday, November 5, 2011 - 2:45pm
tags:
Sequenom
You Should Have Seen These Biotech Failures Coming
Motley Fool
Saturday, November 5, 2011 - 2:44pm
tags:
Oxigene, Rexahn
Illumina Shares Jumped: What You Need to Know
Motley Fool
Saturday, November 5, 2011 - 2:42pm
tags:
Illumina, genomics
Vical Back On The Move
Seeking Alpha
Saturday, November 5, 2011 - 2:37pm
tags:
Vical
Idera Pharmaceuticals Completes $9.5 Million Financing
Yahoo/BusinessWire
Saturday, November 5, 2011 - 2:36pm
tags:
Idera Pharmaceuticals
Medivation Up 140% In One Day, While Dendreon Gets Quartered
Seeking Alpha
Saturday, November 5, 2011 - 2:35pm
tags:
Medivation, Dendreon, Provenge, MDV3100, prostate cancer
Synageva completes acquisition of Trimeris
Bizjournals.com
Friday, November 4, 2011 - 12:56pm
tags:
Synageva, Trimeris, M&A
Emergent BioSolutions' CEO Discusses Q3 2011 Results - Earnings Call Transcript
Seeking Alpha
Friday, November 4, 2011 - 12:46pm
tags:
earnings, Emergent BioSolutions
Data Links High Doses of Bone Drug to Cancer
NY Times, NY
Friday, November 4, 2011 - 12:42pm
tags:
Medtronic, cancer, spinal fusion, infuse
New Medicare code could boost Krystexxa sales
Fierce Pharma
Friday, November 4, 2011 - 12:19pm
tags:
Medicare, Krystexxa, gout, Savient
Celgene to Pump $45M Into Quanticel to Discover Cancer Drugs
Motley Fool
Friday, November 4, 2011 - 12:18pm
tags:
Celgene, Quanticel, oncology
Gout drug developer Ardea reports bigger 3Q loss
Yahoo/AP
Friday, November 4, 2011 - 12:17pm
tags:
Ardea, earnings, gout
Seattle Genetics beats Wall Street predictions for new cancer drug
Bizjournals.com
Friday, November 4, 2011 - 9:31am
tags:
Seattle Genetics, earnings
Inhibitex Soars as Investors See Another Pharmasset in the Making
TheStreet.com
Friday, November 4, 2011 - 9:29am
tags:
Inhibitex, Pharmasset, INX-189, hepatitis C, PSI-7977
Allergan Says Massachusetts AG Wants Documents on Group
Bloomberg
Friday, November 4, 2011 - 9:28am
tags:
Allergan, Massachusetts
Vivus says FDA accepts weight-loss drug application
Reuters
Friday, November 4, 2011 - 9:24am
tags:
FDA, obesity, Vivus, Qnexa
Cornerstone Therapeutics 3Q profit slips
Yahoo/AP
Friday, November 4, 2011 - 9:23am
tags:
earnings, Cornerstone Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.